These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38707117)

  • 1. Human Papillomavirus Vaccination Rates in Patients Living With Human Immunodeficiency Virus (HIV).
    Boivin N; Desai S
    Cureus; 2024 Apr; 16(4):e57558. PubMed ID: 38707117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
    Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.
    Li X; Stander MP; Van Kriekinge G; Demarteau N
    BMC Infect Dis; 2015 Dec; 15():566. PubMed ID: 26652918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On surmounting the barriers to HPV vaccination: we can do better.
    Attia AC; Wolf J; Núñez AE
    Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
    Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
    MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus Prevalence and Vaccination Rates Among Users of Pre-Exposure Prophylaxis for Human Immunodeficiency Virus Prevention.
    Rotert P; Wheldon C; Kownack J; Sullivan-Blum Z; Cokingtin B; Khetani K; Ndeti K; Skyes K; Ramaswamy M
    J Prim Care Community Health; 2022; 13():21501319221110411. PubMed ID: 35972200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low human papillomavirus (HPV) vaccine uptake among men living with human immunodeficiency virus (HIV): Cross-sectional findings from a clinical cohort.
    Grewal R; Grennan T; Gillis JL; Ogilvie G; Gaspar M; Grace D; Raboud JM; MacPherson PA; Rosenes R; Salit IE; Burchell AN;
    Prev Med; 2021 Feb; 143():106329. PubMed ID: 33221269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administering the HPV Vaccine to People Living with HIV: Providers' Perspectives.
    Koskan A; Brennhofer SA; Helitzer D
    J Prim Prev; 2020 Aug; 41(4):349-362. PubMed ID: 32613520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Barriers to HPV Vaccination: Perspectives From Air Force Family Medicine Physicians and Active Duty Air Force Males.
    Halista CE; Kline RJ; Bepko J
    Mil Med; 2020 Jun; 185(5-6):e878-e886. PubMed ID: 31808930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
    Poljak M; Šterbenc A; Lunar MM
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, attitudes, and practices towards HPV vaccination among reproductive age women in a HIV hotspot in the US.
    Villavicencio A; Kelsey G; Nogueira NF; Zukerberg J; Salazar AS; Hernandez L; Raccamarich P; Alcaide ML
    PLoS One; 2023; 18(1):e0275141. PubMed ID: 36656804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions.
    Russ SM; Brackney M; Meek J; Niccolai LM
    Vaccine; 2019 Jul; 37(31):4262-4267. PubMed ID: 31248688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys.
    Sayinzoga F; Tenet V; Heideman DAM; Sibomana H; Umulisa MC; Franceschi S; Hakizimana JD; Clifford GM; Baussano I
    Lancet Glob Health; 2023 Jul; 11(7):e1096-e1104. PubMed ID: 37207683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
    Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
    Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
    Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
    Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus.
    Mavundza EJ; Wiyeh AB; Mahasha PW; Halle-Ekane G; Wiysonge CS
    Hum Vaccin Immunother; 2020; 16(2):426-435. PubMed ID: 31448991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus Vaccinations: Provider Education to Enhance Vaccine Uptake.
    Kopp SA; Turk DE
    Clin Pediatr (Phila); 2023 Sep; 62(8):840-848. PubMed ID: 36655653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to cervical cancer prevention in a safety net clinic: gaps in HPV vaccine provider recommendation and series completion among Ob/Gyn patients.
    Finch LA; Levy MS; Thiele A; Jeudin P; Huang M
    Front Oncol; 2024; 14():1359160. PubMed ID: 38606100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Countering Antivax Misinformation via Social Media: Message-Testing Randomized Experiment for Human Papillomavirus Vaccination Uptake.
    Kim SJ; Schiffelbein JE; Imset I; Olson AL
    J Med Internet Res; 2022 Nov; 24(11):e37559. PubMed ID: 36422887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.